Literature DB >> 23085759

The Cul4A-DDB1 E3 ubiquitin ligase complex represses p73 transcriptional activity.

M Malatesta1, A Peschiaroli, E M Memmi, J Zhang, A Antonov, D R Green, N A Barlev, A V Garabadgiu, P Zhou, G Melino, F Bernassola.   

Abstract

The Cullin4A (cul4A)-dependent ligase (CDL4A) E3 has been implicated in a variety of biological processes, including cell cycle progression and DNA damage response. Remarkably, CDL4A exerts its function through both proteolytic and non-proteolytic events. Here, we show that the p53 family member p73 is able to interact with the CDL4A complex through its direct binding to the receptor subunit DNA-binding protein 1 (DDB1). As a result, the CDL4A complex is able to monoubiquitylate p73. Modification of p73 by CDL4A-mediated ubiquitylation does not affect p73 protein stability, but negatively regulates p73-dependent transcriptional activity. Indeed, genetic or RNA interference-mediated depletion of DDB1 induces the expression of several p73 target genes in a p53-independent manner. In addition, by exploiting a bioinformatic approach, we found that elevated expression of Cul4A in human breast carcinomas is associated with repression of p73 target genes. In conclusion, our findings add a novel insight into the regulation of p73 by the CDL4A complex, through the inhibition of its transcriptional function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23085759     DOI: 10.1038/onc.2012.463

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes.

Authors:  Alexey G Mittenberg; Valeria O Kuzyk; Sergey V Shabelnikov; Daria P Gorbach; Alla N Shatrova; Olga A Fedorova; Nickolai A Barlev
Journal:  Cell Cycle       Date:  2018-08-01       Impact factor: 4.534

2.  p63 controls cell migration and invasion by transcriptional regulation of MTSS1.

Authors:  A Giacobbe; M Compagnone; L Bongiorno-Borbone; A Antonov; E K Markert; J H Zhou; M Annicchiarico-Petruzzelli; G Melino; A Peschiaroli
Journal:  Oncogene       Date:  2015-06-29       Impact factor: 9.867

3.  Targetome profiling and functional genetics implicate miR-618 in lymphomagenesis.

Authors:  Alan Fu; Aaron E Hoffman; Ran Liu; Daniel I Jacobs; Tongzhang Zheng; Yong Zhu
Journal:  Epigenetics       Date:  2014-02-06       Impact factor: 4.861

4.  DNA damage-induced ubiquitylation of proteasome controls its proteolytic activity.

Authors:  Tatiana N Moiseeva; Andrew Bottrill; Gerry Melino; Nickolai A Barlev
Journal:  Oncotarget       Date:  2013-09

5.  High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy.

Authors:  M Rossi; B Rotblat; K Ansell; I Amelio; M Caraglia; G Misso; F Bernassola; C N Cavasotto; R A Knight; A Ciechanover; G Melino
Journal:  Cell Death Dis       Date:  2014-05-01       Impact factor: 8.469

Review 6.  Regulation of the DNA damage response by ubiquitin conjugation.

Authors:  Kerstin Brinkmann; Michael Schell; Thorsten Hoppe; Hamid Kashkar
Journal:  Front Genet       Date:  2015-03-10       Impact factor: 4.599

Review 7.  The emerging role for Cullin 4 family of E3 ligases in tumorigenesis.

Authors:  Ji Cheng; Jianping Guo; Brian J North; Kaixiong Tao; Pengbo Zhou; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-12-30       Impact factor: 10.680

Review 8.  CUL4A ubiquitin ligase: a promising drug target for cancer and other human diseases.

Authors:  Puneet Sharma; Alo Nag
Journal:  Open Biol       Date:  2014-02-12       Impact factor: 6.411

Review 9.  Lysine-specific modifications of p53: a matter of life and death?

Authors:  Diana Marouco; Alexander V Garabadgiu; Gerry Melino; Nikolai A Barlev
Journal:  Oncotarget       Date:  2013-10

10.  Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway.

Authors:  Jun Deng; Wan Lei; Xiaojun Xiang; Ling Zhang; Jun Lei; Yu Gong; Meijiao Song; Yi Wang; Ziling Fang; Feng Yu; Miao Feng; Ze Sun; Jun Chen; Zhengyu Zhan; Jianping Xiong
Journal:  Oncotarget       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.